bioMérieux S.A. (EPA:BIM)
99.30
-2.70 (-2.65%)
At close: Jan 28, 2026
bioMérieux Market Cap
bioMérieux has a market cap or net worth of €11.72 billion as of January 28, 2026. Its market cap has decreased by -10.17% in one year.
Market Cap
11.72B
Enterprise Value
11.85B
Revenue
4.12B
Ranking
n/a
PE Ratio
31.33
Stock Price
€99.30
Market Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 1.18B to 11.72B, an increase of 890.53%. That is a compound annual growth rate of 11.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 12.04B | -7.52% |
| Dec 31, 2025 | 13.02B | 6.63% |
| Dec 31, 2024 | 12.21B | 2.78% |
| Dec 29, 2023 | 11.88B | 2.52% |
| Dec 30, 2022 | 11.59B | -21.58% |
| Dec 31, 2021 | 14.78B | 8.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 119.04B |
| Sanofi | 96.41B |
| Sartorius Stedim Biotech | 19.89B |
| Eurofins Scientific SE | 12.58B |
| Ipsen | 11.44B |
| ABIVAX Société Anonyme | 7.86B |
| Virbac | 3.09B |
| emeis Société anonyme | 2.31B |